Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Ovarian cancer survival varies between high-income countries

Key clinical point: A retrospective study suggests considerable differences in ovarian cancer survival exist between high-income countries, particularly for older patients with advanced disease.

Major finding: The 3-year all-ages net survival was highest for Norway (57%) and Australia (56%), with an overall range of 45%-57% between seven countries.

Study details: A population-based retrospective analysis of 58,161 women with ovarian cancer.

Disclosures: The study was supported by funding provided to the International Cancer Benchmarking Partnership. The authors reported having no conflicts of interest.

Citation:

Cabasag CJ et al. Gynecol Oncol. 2020 Jan 28. doi: 10.1016/j.ygyno.2019.12.047.